User menu

Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods.

Primary tabs
Add to cart
Print
Copyright (Sherpa/Romeo)
References35
Authors :
Document type : Article de périodique (Journal article) – Journal Article, Research Support, Non-U.S. Gov't
Abstract :

BACKGROUND: Our previous studies on the effects of acamprosate on enhanced locomotion during repeated withdrawals are now extended to the effects of acamprosate on excitatory amino acids in the hippocampus during repeated ethanol withdrawals. METHODS: In this study, Wistar rats were made ethanol dependent by 4 weeks of vapor inhalation. After this first cycle of chronic ethanol treatment, rats underwent repeated and alternate cycles of 24 hr withdrawals and 1 week of chronic ethanol treatment. The microdialysis technique was used together with high-performance liquid chromatography and electrochemical detection to quantify different amino acids such as aspartate and glutamate. RESULTS: An intraperitoneal administration of acamprosate (400 mg/kg) to naïve rats did not alter aspartate or glutamate levels compared with the saline groups. During the first cycle of ethanol withdrawal, the administration of acamprosate (400 mg/kg, intraperitoneally) 2 hr after the commencement of ethanol withdrawal decreased both aspartate and glutamate microdialysate levels when compared with their respective saline group. Acamprosate administration also significantly decreased glutamate levels during the third withdrawal compared with the saline group, whereas no changes were seen in aspartate levels. CONCLUSION: The results of this work demonstrate that acamprosate reduced the excitatory amino acid glutamate increase observed during repeated ethanol withdrawal. These effects of acamprosate may provide a protective mechanism against neurotoxicity by reducing excitatory amino acids, particularly glutamate.
Publication date : 2003
Journal information : "Alcoholism, clinical and experimental research" - Vol. 27, no. 3, p. 465-70 (2003)
Peer reviewed : yes
issn : 0145-6008
Publication status : Publié
Affiliation : UCL - SC/BIOL - Département de biologie
MESH Subject : Animals ; Ethanol - pharmacology ; Excitatory Amino Acids - antagonists & inhibitors - metabolism ; Hippocampus - drug effects - metabolism ; Male ; Rats ; Rats, Wistar ; Substance Withdrawal Syndrome - metabolism ; Taurine - analogs & derivatives - pharmacology
Links :
Bibliographic reference Dahchour, Abdelkader ; De Witte, Philippe. Effects of acamprosate on excitatory amino acids during multiple ethanol withdrawal periods.. In: Alcoholism, clinical and experimental research, Vol. 27, no. 3, p. 465-70 (2003)
Permanent URL http://hdl.handle.net/2078.1/9415

References Provided by I4OC

  1. al Qatari M, Alcohol Clin Exp Res, 22, 810 (1998)
  2. al Qatari Mona, Khan Shabeena, Harris Barton, Littleton John, Acamprosate Is Neuroprotective Against Glutamate-Induced Excitotoxicity When Enhanced by Ethanol Withdrawal in Neocortical Cultures of Fetal Rat Brain, 10.1111/j.1530-0277.2001.tb02348.x
  3. Allgaier Clemens, Franke Heike, Sobottka Helga, Scheibler Peter, Acamprosate inhibits Ca2+ influx mediated by NMDA receptors and voltage-sensitive Ca2+ channels in cultured rat mesencephalic neurones, 10.1007/s002100000285
  4. Becker Howard C., Diaz-Granados Jaime L., Weathersby R.T., Repeated ethanol withdrawal experience increases the severity and duration of subsequent withdrawal seizures in mice, 10.1016/s0741-8329(97)87949-9
  5. Becker Howard C., Hale Robert L., Repeated Episodes of Ethanol Withdrawal Potentiate the Severity of Subsequent Withdrawal Seizures: An Animal Model of Alcohol Withdrawal "Kindling", 10.1111/j.1530-0277.1993.tb00731.x
  6. Boismare F, Pharmacol Biochem Behav, 21, 787 (1984)
  7. Bolo Nicolas, Nédélec Jean-François, Muzet Muriel, De Witte Philippe, Dahchour Abdelkader, Durbin Philippe, Macher Jean-Paul, Central effects of acamprosate: Part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers, 10.1016/s0925-4927(98)00017-1
  8. Dahchour Abdelkader, De Witte Philippe, Acamprosate Decreases the Hypermotility During Repeated Ethanol Withdrawal, 10.1016/s0741-8329(98)00071-8
  9. Dahchour Abdelkader, De Witte Philippe, Bolo Nicolas, Nédélec Jean-François, Muzet Muriel, Durbin Philippe, Macher Jean-Paul, Central effects of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats, 10.1016/s0925-4927(98)00016-x
  10. Donzanti Bruce A., Yamamoto Bryan K., An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates, 10.1016/0024-3205(88)90267-6
  11. Douglas RM, Psychol Bull, 67, 416 (1967)
  12. French ED, Adv Exp Med Biol, 203, 349 (1986)
  13. Gewiss M, Alcohol Alcohol, 26, 129 (1991)
  14. JA Gray (1982 ) The Neuropsychology of Anxiety . Oxford University Press, Oxford, UK.
  15. Heyser C, Chronic Acamprosate Eliminates the Alcohol Deprivation Effect While Having Limited Effects on Baseline Responding for Ethanol in Rats, 10.1016/s0893-133x(97)00130-9
  16. Holter SM, Alcohol Clin Exp Res, 21, 862 (1997)
  17. Kontro P., Oja S.S., Release of taurine, GABA and dopamine from rat striatal slices: Mutual interactions and developmental aspects, 10.1016/0306-4522(88)90310-7
  18. Kratzer U, Schmidt W.J, The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats, 10.1016/s0304-3940(98)00550-3
  19. LeBourhis B, Comptes rendus des seances de la Societe de Biologie, 169, 898 (1975)
  20. Le Magnen J., Tran G., Durlach J., Martin C., Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate, 10.1016/0741-8329(87)90005-x
  21. McCown Thomas J., Breese George R., Multiple Withdrawals from Chronic Ethanol "Kindles" Inferior Collicular Seizure Activity: Evidence for Kindling of Seizures Associated with Alcoholism, 10.1111/j.1530-0277.1990.tb00492.x
  22. Naassila M, Alcohol Clin Exp Res, 22, 802 (1998)
  23. Oja S. S., Korpi E. R., Saransaari Pirjo, Modification of chloride flux across brain membranes by inhibitory amino acids in developing and adult mice, 10.1007/bf00968557
  24. Paille FM, Alcohol Alcohol, 30, 239 (1995)
  25. G Paxinos, and C Watson (1982 ) The Rat Brain, in Stereotaxic Coordinates . Academic Press, New York.
  26. Poldrugo Flavio, Snead O. Carter, Electroencephalographic and behavioral correlates in rats during repeated ethanol withdrawal syndromes, 10.1007/bf00429722
  27. Popp R.Lisa, Lovinger David M, Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons, 10.1016/s0014-2999(00)00195-3
  28. Putzke Jörg, Spanagel Rainer, Tölle Thomas R., Zieglgänsberger Walter, The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal, 10.1016/s0014-2999(96)00696-6
  29. Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, Spanagel R, Zieglgänsberger W, Schadrack J, The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801, 10.1016/s0028-3908(01)00008-9
  30. Sass H, Arch Gen Psychiatry, 53, 673 (1996)
  31. Spanagel Rainer, Hölter Sabine M., Allingham Karl, Landgraf Rainer, Zieglgänsberger Walter, Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat, 10.1016/0014-2999(96)00174-4
  32. Spanagel R, Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes, 10.1016/s0165-6147(96)01026-7
  33. RD Traub, and R Miles (1991 ) Neuronal Networks of the Hippocampus . Cambridge University Press, Cambridge, UK.
  34. Trenkner E, Adv Exp Med Biol, 268, 239 (1990)
  35. Veatch Lynn M., Gonzalez Larry P., Repeated Ethanol Withdrawal Produces Site-Dependent Increases in EEG Spiking, 10.1111/j.1530-0277.1996.tb01638.x